UK markets open in 22 minutes
NIKKEI 225
27,049.47 +178.20 (+0.66%) HANG SENG
22,361.32 +131.80 (+0.59%) CRUDE OIL
111.13 +1.56 (+1.42%) GOLD FUTURES
1,828.80 +4.00 (+0.22%) DOW
31,438.26 -62.42 (-0.20%) BTC-GBP
16,967.77 -378.62 (-2.18%)
Merck & Co., Inc. (0QAH.L)
LSE - LSE Delayed price. Currency in EUR
Add to watchlist
At close: 02:41PM BST
| Previous close | N/A |
| Open | 74.85 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 74.85 - 74.85 |
| 52-week range | 74.85 - 74.85 |
| Volume | |
| Avg. volume | N/A |
| Market cap | N/A |
| Beta (5Y monthly) | 0.37 |
| PE ratio (TTM) | 13.40 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
LYNPARZA® (olaparib) Receives Positive Opinion From EU CHMP as Adjuvant Treatment for Germline BRCA-Mutated, HER2-Negative High-Risk Early Breast Cancer
RAHWAY, N.J., June 27, 2022--LYNPARZA® Receives Positive Opinion From EU CHMP as Adjuvant Treatment for Germline BRCA-Mutated, HER2-Negative High-Risk Early Breast Cancer
- Business Wire
European Commission Approves KEYTRUDA® (pembrolizumab) as Adjuvant Treatment for Adult and Adolescent Patients (≥12 Years of Age) With Stage IIB or IIC Melanoma Following Complete Resection
RAHWAY, N.J., June 24, 2022--European Commission Approves KEYTRUDA as Adjuvant Treatment for Adult & Adolescent Patients With Stage IIB or IIC Melanoma After Complete Resection
- Business Wire
CDC’s ACIP Unanimously Votes to Provisionally Recommend Use of Merck’s VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) as an Option for Pneumococcal Vaccination in Infants and Children
RAHWAY, N.J., June 22, 2022--CDC’s ACIP Unanimously Votes to Provisionally Recommend Use of Merck’s VAXNEUVANCE™ as an Option for Pneumococcal Vaccination in Infants and Children
© 2022 Yahoo. All rights reserved.
